Skip to content

The Joint Corp. JYNT Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Regis Corporation logo
Regis CorporationRGS
LifeMD, Inc. logo
LifeMD, Inc.LFMD
Dine Brands Global logo
Dine Brands GlobalDIN
Papa John's International logo
Papa John's InternationalPZZA
Wendy's logo
Wendy'sWEN
Teladoc Health logo
Teladoc HealthTDOC

Other financials

Income statement

See full
Revenue$14.8M+13.3%
Gross profit$12.1M+19.7%
Operating income$873.7K+229%
Net income$1.3M+34.2%
EPS (diluted)$0.09+50.0%

Balance sheet

See full
Cash & equivalents$21.4M-6.4%
Total debt$2.0M-9.3%
Total equity$15.5M-22.3%
Total assets$57.9M-25.0%

Cash flow

See full
Operating cash flow-$1.5M+60.1%
CapEx$234.6K-29.2%
Free cash flow-$1.7M+57.6%

Valuation

See full
Market cap$127.87M-28.0%
Enterprise value$108.49M-27.1%
P/E39.5×
P/S2.3×-0.2×

Profitability

See full
Gross margin80.6%-6.0pp
Operating margin1.1%+0.7pp
Net margin5.7%+3.7pp
FCF margin7.2%-0.4pp

Returns & leverage

See full
Return on equity18.3%+11.6pp
Debt / equity0.1×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by The Joint Corp. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: The Joint Corp.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Joint Corp.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Joint Corp.'s common stock, shares authorized (in shares)?
The Joint Corp. (JYNT) reported common stock, shares authorized (in shares) of $20M in Q1 2026.
How has The Joint Corp.'s common stock, shares authorized (in shares) changed year-over-year?
The Joint Corp.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $20M to $20M.
What is the long-term trend for The Joint Corp.'s common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), The Joint Corp.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $20M to $20M.